Similarly, quercetagitrin enhanced the inhibitory effects of defactinib and ponatinib on the expression of CDK7/9, Ki67, and LYVE1 in primary tumor tissues (Supplementary Fig. 21b) and the activation and expression of Yamanaka transcription factors in lymph nodes (Supplementary Fig. 21c). This evidence concerns the gene MKI67 and neoplasm.